PRO-C3 is a predictor of clinical outcomes in distinct cohorts of patients with advanced liver disease

BACKGROUND & AIMS: Fibroblast activity is a key feature of fibrosis progression and organ function loss, leading to liver-related complications and mortality. The fibrogenesis marker, PRO-C3, has been shown to have prognostic significance in relation to fibrosis progression and as a treatment ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Nielsen, Mette J., Dolman, Grace E., Harris, Rebecca, Frederiksen, Peder, Chalmers, Jane, Grove, Jane I., Irving, William L., Karsdal, Morten A., Patel, Keyur, Leeming, Diana Julie, Guha, Indra Neil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240276/
https://www.ncbi.nlm.nih.gov/pubmed/37284140
http://dx.doi.org/10.1016/j.jhepr.2023.100743

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240276/
https://www.ncbi.nlm.nih.gov/pubmed/37284140
http://dx.doi.org/10.1016/j.jhepr.2023.100743

Ejemplares similares